U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Carboplatin Injection
Status: Currently in Shortage
»Date first posted: 04/28/2023
»Therapeutic Categories: Oncology

Expand all

Accord Healthcare Inc. (Revised 05/06/2024)

Company Contact Information:
866-941-7875, option 2

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 16729-295-34) Available, 30 days
Injection, 10 mg/1 mL (NDC 16729-295-12) Available
Injection, 10 mg/1 mL (NDC 16729-295-33) Unavailable Resupply TBD Requirements related to complying with good manufacturing practices
Injection, 10 mg/1 mL (NDC 16729-295-31) Unavailable Temporarily discontinued Discontinuation of the manufacture of the drug

Eugia US LLC (Revised 04/17/2024)

Company Contact Information:
888-238-7880

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01) Available Intermittent availability expected Demand increase for the drug
Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01) Available Intermittent availability expected Demand increase for the drug

Fresenius Kabi USA, LLC (Reverified 05/08/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 63323-172-60) Available Check wholesaler for inventory

Gland Pharma Limited (Revised 03/15/2024)

Company Contact Information:
Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01) Available Distributed by BPI Labs, LLC
Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01) Available Distributed by BPI Labs, LLC
Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01) Available Distributed by BPI Labs, LLC
Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01) Available Distributed by BPI Labs, LLC

Hospira, Inc., a Pfizer Company (Revised 05/24/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18) Available
Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18) Available
Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22) Available
Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05) Available
Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50) Available
Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05) Limited Availability Limited Supply Available. Next Delivery: August 2024; Estimated Recovery: September 2024 Demand increase for the drug
Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56) Limited Availability Limited Availability. Next Delivery: May 2024; Estimated Recovery: September 2024 Demand increase for the drug
Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05) Limited Availability Limited Supply Available. Next Delivery and Estimated Recovery: September 2024 Demand increase for the drug

Ingenus Pharmaceuticals LLC (Revised 03/04/2024)

Company Contact Information:
866-321-5031

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 600 mg/60 mL (NDC 50742-448-60) Available For any other information, please contact the Ingenus Customer Service team at 866-321-5031.
Injection, 450 mg/45 mL (NDC 50742-447-45) Available For any other information, please contact the Ingenus Customer Service team at 866-321-5031.

Teva Pharmaceuticals USA, Inc. (Revised 05/15/2024)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 0703-4239-01) Limited Availability Estimated recovery July 2024 Demand increase for the drug
Injection, 10 mg/1 mL (NDC 0703-4244-01) Available
Injection, 10 mg/1 mL (NDC 0703-4246-01) Available
Injection, 10 mg/1 mL (NDC 0703-4248-01) Available

Teyro Labs (Reverified 04/23/2024)

Company Contact Information:
800-706-5575 (Apotex Inc.)

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 60505-6282-1) Available Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Injection, 10 mg/1 mL (NDC 60505-6282-3) Available Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Injection, 10 mg/1 mL (NDC 60505-6282-6) Available Wholesaler & Distributor through Marketing partner (Apotex Inc.)
Back to Top